asparagine has been researched along with Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atobe, T; Hara, H; Kadowaki, M; Kamiya, T; Kunieda, K; Morimoto, K | 1 |
| Bardin, S; Baudrie, V; Bernstein, KE; Billet, S; Clauser, E; Conchon, S; Corvol, P; Elghozi, JL; Escoubet, B; Gasc, JM; Hamard, G; Michaud, A; Muffat-Joly, M; Souil, E; Verp, S | 1 |
2 other study(ies) available for asparagine and Cirrhosis
| Article | Year |
|---|---|
Inhibition of N-glycosylation by glucosamine hydrochloride inhibits TGF-β1-induced LOXL2 secretion.
Topics: Amino Acid Oxidoreductases; Asparagine; Fibrosis; Glucosamine; Glycosylation; Humans; Renal Insufficiency, Chronic; Transforming Growth Factor beta1 | 2023 |
Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice.
Topics: Angiotensins; Animals; Asparagine; Blood Pressure; Cardiovascular Diseases; Disease Progression; Female; Fibrosis; Gene Expression Regulation; Hyperaldosteronism; Hypertension; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Receptor, Angiotensin, Type 1; Renin; Signal Transduction | 2007 |